Cardiogen
Cardiogen (Heart Bioregulator)
Cardiogen is a short-chain tetrapeptide bioregulator (Ala-Glu-Asp-Arg) derived from cardiac tissue, developed by the St. Petersburg Institute of Bioregulation and Gerontology. It is primarily used to support cardiac function, promote cardiomyocyte regeneration, and regulate gene expression within heart tissue, with applications in age-related cardiac decline, post-infarction recovery support, and general cardiovascular health maintenance.
Mechanism of Action
Cardiogen functions as a peptide bioregulator that penetrates cell nuclei and binds to specific DNA promoter regions, upregulating transcription of genes involved in cardiomyocyte differentiation, proliferation, and protein synthesis. It is believed to normalize chromatin activity in cardiac cells, restore protein synthesis rates in aging or damaged myocardial tissue, and modulate expression of structural cardiac proteins. Research suggests it may also stimulate stem cell differentiation toward cardiac lineages and exert antioxidant effects within myocardial tissue.
Evidence by Health Goal(6 goals)
Dosing Protocols
Morning, held under tongue for 1-2 minutes before swallowing
Cycle: 10 days on, repeat 3-6 months later
Sublingual administration is preferred to maximize bioavailability and bypass first-pass hepatic metabolism; this is the most commonly referenced protocol in Russian clinical literature
On empty stomach, 30 minutes before breakfast
Cycle: 10-day course, repeated 2-3 times per year
Oral capsule form is commercially available (e.g., Chelohart); bioavailability is lower than sublingual but practical for longer maintenance protocols
Safety & Side Effects
Cardiogen has a relatively favorable short-term safety profile based on Russian clinical and experimental studies, with no significant toxicity reported at recommended doses; however, long-term safety data from large, independent, peer-reviewed randomized controlled trials is limited, and individuals with active cardiac pathology, arrhythmias, or those on cardiac medications should consult a cardiologist before use.
Possible Side Effects
- !Generally well-tolerated with rare adverse events reported in available literature
- !Mild transient hypotension in individuals with already low baseline blood pressure
- !Sublingual mild irritation or tingling at administration site
- !Rare allergic or hypersensitivity reactions to peptide components
- !Theoretical risk of excessive promotion of cardiac cell proliferation with prolonged unsupervised use
- !Gastrointestinal discomfort (mild nausea) with oral dosing in sensitive individuals
Interactions
- -May potentiate antihypertensive medications - use caution and monitor blood pressure when combining with ACE inhibitors, beta-blockers, or calcium channel blockers
- -Potential additive effects with other cardiac-supportive supplements such as CoQ10 or magnesium - generally considered safe but monitor hemodynamic response
- -May theoretically interact with anticoagulants (warfarin, apixaban) if it influences vascular endothelial gene expression - caution advised
- -Concurrent use with other peptide bioregulators (e.g., Epitalon, Thymalin) is practiced in Russian longevity protocols but lacks formal interaction data
- -Caution in individuals taking antiarrhythmic drugs due to unknown additive electrophysiological effects
Cost & Where to Buy
Cardiogen is available commercially as Chelohart capsules from Cytomax/NPO Peptides (Russia) and through specialty longevity or peptide vendors; pricing depends on whether purchasing the commercial Russian formulation or research-grade synthetic peptide, and per-course (10-day) cost is relatively low but monthly equivalent varies by cycling frequency
Search on Amazon